Pinealon

Quick Facts

Introduction

Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (EDR), part of the family of ultra-short peptide bioregulators developed within the research tradition associated with Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. These compounds are studied for the hypothesis that very small peptides can act as signaling molecules that influence gene expression in specific tissues — a framework often described in the literature on Khavinson peptide science.

Within this class, pinealon is examined mainly in a neurological context. Preclinical research has studied it for its association with the survival and differentiation of neurons exposed to hypoxia and oxidative stress, placing it conceptually alongside other neuroactive research peptides such as Cortexin and Cerebrolysin. It shares the broad bioregulator concept with the pineal tetrapeptide Epitalon.

This profile covers what pinealon is, its tripeptide structure, the proposed gene-regulatory mechanism that defines the short-peptide class, the neuroprotection research it appears in, and how it compares with related neuroactive compounds. Related entries are catalogued in the peptide database, and broader context appears in the research library.

What is Pinealon?

Pinealon is a synthetic tripeptide composed of three amino acids — glutamic acid, aspartic acid, and arginine. Its small size is central to the research hypothesis surrounding it: the short-peptide bioregulator model proposes that peptides of just two to four residues are small enough to enter cells and even the nucleus, where they are studied as potential modulators of transcription rather than as classic receptor ligands.

The name reflects its conceptual association with the pineal gland and the broader family of regulatory peptides studied for effects on neural and neuroendocrine tissue. Unlike larger signaling peptides that act on a defined cell-surface receptor, pinealon is investigated under the premise that short peptides may interact directly with regions of DNA or with chromatin-associated proteins, a mechanism that remains an active area of study rather than settled science.

Molecular and structural characteristics

Structurally, pinealon is among the simplest peptides studied in neuroscience research: a linear chain of three residues joined by two peptide bonds. Its sequence combines two acidic residues (glutamate and aspartate) with the basic, guanidinium-bearing arginine, giving the molecule both negatively and positively charged groups. Researchers have proposed that this charge distribution is relevant to the hypothesis that EDR-type peptides can associate with the charged backbone of DNA.

Because it carries no large hydrophobic regions, the tripeptide is highly water-soluble and lacks the secondary structure (helices or sheets) seen in larger peptides. Its small molecular weight, near 418 g/mol, is far below that of multi-residue signaling peptides and is one reason researchers frame its proposed activity in terms of direct nuclear access rather than surface-receptor binding.

Mechanism of action

The defining mechanistic hypothesis for pinealon and the EDR class is direct modulation of gene expression. Research in this tradition proposes that short peptides penetrate the cell and nuclear membranes and interact with specific nucleotide sequences or chromatin proteins, thereby influencing the transcription of particular genes. This is distinct from the receptor-and-second-messenger model that governs most peptide signaling, and it remains a debated, actively studied proposal rather than an established pathway.

In neural research models, pinealon is studied for its association with antioxidant defenses and anti-apoptotic signaling. Reports have linked exposure to reduced markers of oxidative damage and to preserved expression of factors involved in neuronal survival, which researchers interpret as consistent with a stress-protective role. These observations are typically made in cell culture and animal models exposed to hypoxia or reactive-oxygen challenge.

A related theme is the maintenance of neuronal differentiation and viability. In cultured neurons, the peptide has been examined for its capacity to support continued differentiation and to limit cell death under adverse conditions, mechanisms that connect it conceptually to other neuroactive research peptides catalogued in the research library.

• Proposed direct interaction with DNA/chromatin to modulate gene transcription.
• Association with upregulated antioxidant defenses in neural models.
• Anti-apoptotic signaling under hypoxic and oxidative stress.
• Support of neuronal differentiation and viability in culture.

Neuroprotection and oxidative-stress research

The core research context for pinealon is neuroprotection under stress. Preclinical studies have applied the peptide in models of hypoxia, prenatal stress, and oxidative challenge, examining endpoints such as neuronal survival, markers of lipid peroxidation, and behavioral measures in rodents. The recurring theme in this literature is an association between EDR exposure and reduced indicators of oxidative and hypoxic damage.

Researchers have also studied pinealon in the context of cognitive and behavioral endpoints in animals subjected to developmental or environmental stressors, where it is examined for associations with preserved learning and memory performance. These findings are framed as research observations in specific models and are not evidence of cognitive benefit in humans.

Short-peptide bioregulator research context

Pinealon belongs to a broader family of short peptide bioregulators studied for tissue-specific effects. The unifying hypothesis of this field is that di-, tri-, and tetrapeptides derived from or modeled on natural tissue peptides can act as epigenetic-style signals, nudging gene expression in the tissues from which they originate. The pineal tetrapeptide Epitalon is the most-studied member and serves as the reference compound for the class.

This conceptual framework links pinealon to neuropeptide preparations studied for cognitive endpoints, including the brain-derived complexes Cortexin and Cerebrolysin. While those are heterogeneous mixtures rather than defined tripeptides, all are studied within the same research conversation about peptide signaling in the nervous system, summarized across the research library.

Comparison: Pinealon vs Epitalon vs Cortexin

Pinealon is most often compared with Epitalon, the pineal tetrapeptide that anchors the Khavinson short-peptide class, and with Cortexin, a brain-derived polypeptide complex studied for neurological endpoints. All three appear in the neuroactive bioregulator literature, but they differ in structure and primary research focus.

Researchers studying short peptides often examine these compounds side by side because they share the bioregulator hypothesis while differing in molecular definition. Full entries for each are in the peptide database.

Half-life and pharmacokinetic considerations

As a very small peptide, pinealon is expected to have a short circulating half-life, since tripeptides are rapidly hydrolyzed by ubiquitous peptidases. This is a general property of the short-peptide class, and detailed human pharmacokinetic data are not well established; most interpretation relies on preclinical models.

Researchers in this field sometimes argue that a brief systemic presence is compatible with the proposed mechanism if even transient nuclear interaction is sufficient to influence transcription. This remains a hypothesis-driven area, and pharmacokinetic figures should be treated as approximate and model-dependent rather than firmly characterized.

Reconstitution and handling considerations

Pinealon is supplied as a lyophilized powder and reconstituted with sterile or bacteriostatic water, added slowly down the vial wall and swirled gently rather than shaken. Because the tripeptide is highly water-soluble, it dissolves readily; the resulting solution should be clear, and cloudiness or particulates indicate it should be discarded.

Working concentration is chosen so research volumes are convenient and reproducible. The reconstitution calculator and reconstitution guide describe the general method used across peptide research.

• Add diluent slowly; swirl gently rather than shaking.
• Confirm the solution is clear before use.
• Label vials with concentration and reconstitution date.
• Protect from light and excess warmth.

Storage considerations

Lyophilized pinealon is most stable frozen at −20 °C, kept dry and away from light. Once reconstituted, it is refrigerated at 2–8 °C and used within a limited window; aliquoting reduces how often a given solution is freeze–thaw cycled, which is especially relevant for small peptides prone to degradation.

Research limitations

Pinealon is an investigational research compound, and its evidence base is narrower than that of mainstream peptides. The proposed gene-regulatory mechanism is intriguing but not fully established, much of the data come from a limited number of research groups, and human clinical evidence is sparse. Reported effects are model-, dose-, and design-dependent, and it is described here strictly for research reference.

• The direct gene-regulation mechanism remains a hypothesis under study.
• Most data are preclinical (cell-culture and rodent models).
• Human clinical evidence is limited.
• It is not an approved therapy and is described solely for research reference.

Frequently Asked Questions

Related Research Profiles

References

1. Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144.Source
2. Khavinson VKh, Linkova NS, Tarnovskaya SI, et al. Short peptides regulate gene expression, protein synthesis and enzyme activity (review). Bulletin of Experimental Biology and Medicine.
3. Arutjunyan A, Kozina L, Stvolinskiy S, et al. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia / oxidative-stress models (preclinical study). Journal of Molecular Histology.